Showing results (91-100 of 262) with videos related to
Sort By:
Pageof 27
Diabetologia|July 1, 1981
Lymphocytes from diabetics suppress insulin release in vitroC Boitard, M Debray-Sachs, A Pouplard, et al.Diabetes|January 1, 1996
Long-term results of early cyclosporin therapy in juvenile IDDMG De Filippo, J C Carel, C Boitard, et al.Clinical and Experimental Immunology|March 1, 1984
Anti-pancreatic immunity. In vitro studies of cellular and humoral immune reactions directed toward pancreatic isletsC Boitard, P Saï, M Debray-Sachs, et al.Clinical and Experimental Immunology|January 1, 1983
Anti-pancreatic immunity in genetically diabetic miceM Debray-Sachs, P Saï, C Boitard, et al.Presse Medicale (Paris, France : 1983)|December 10, 1999
[Type 1 diabetes mellitus]E Larger, D Dubois-Laforgue, J TimsitClinical Pharmacokinetics|November 1, 1993
Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumoursP Chanson, J Timsit, A G HarrisDiabetes & Metabolism|September 30, 2000
[Is diabetes mellitus a sufficient condition to suspect hemochromatosis?]D Dubois-Laforgue, E Larger, J TimsitHuman Immunology|July 31, 1998
HLA class II-associated predisposition to insulin-dependent diabetes mellitus in a Polish populationM Krokowski, J Bodalski, A Bratek, et al.Presse Medicale (Paris, France : 1983)|December 18, 1993
[Octreotide, analog of somatostatin. Pharmacological properties and therapeutic applications in pituitary endocrine tumors]P Chanson, J Timsit, A G HarrisGenomics|June 2, 2001
Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strainsU C Rogner, C Boitard, J Morin, et al.Pageof 27